227 related articles for article (PubMed ID: 17462407)
1. Ratio of the maximum standardized uptake value on FDG-PET of the mediastinal (N2) lymph nodes to the primary tumor may be a universal predictor of nodal malignancy in patients with nonsmall-cell lung cancer.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2007 May; 83(5):1826-9; discussion 1829-30. PubMed ID: 17462407
[TBL] [Abstract][Full Text] [Related]
2. Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer.
Bryant AS; Cerfolio RJ; Klemm KM; Ojha B
Ann Thorac Surg; 2006 Aug; 82(2):417-22; discussion 422-3. PubMed ID: 16863739
[TBL] [Abstract][Full Text] [Related]
3. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of primary tumor FDG uptake for occult mediastinal lymph node involvement in clinically N2/N3 node-negative non-small cell lung cancer.
Trister AD; Pryma DA; Xanthopoulos E; Kucharczuk J; Sterman D; Rengan R
Am J Clin Oncol; 2014 Apr; 37(2):135-9. PubMed ID: 23111361
[TBL] [Abstract][Full Text] [Related]
5. Metabolic tumor heterogeneity analysis by F-18 FDG PET/CT predicts mediastinal lymph node metastasis in non-small cell lung cancer patients with clinically suspected N2.
Pahk K; Chung JH; Yi E; Kim S; Lee SH
Eur J Radiol; 2018 Sep; 106():145-149. PubMed ID: 30150037
[TBL] [Abstract][Full Text] [Related]
6. Ratio between maximum standardized uptake value of N1 lymph nodes and tumor predicts N2 disease in patients with non-small cell lung cancer in 18F-FDG PET-CT scan.
Honguero Martínez AF; García Jiménez MD; García Vicente A; López-Torres Hidalgo J; Colon MJ; van Gómez López O; Soriano Castrejón ÁM; León Atance P
Rev Esp Med Nucl Imagen Mol; 2016; 35(3):159-64. PubMed ID: 26514322
[TBL] [Abstract][Full Text] [Related]
7. Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small-cell lung cancer.
Perigaud C; Bridji B; Roussel JC; Sagan C; Mugniot A; Duveau D; Baron O; Despins P
Eur J Cardiothorac Surg; 2009 Oct; 36(4):731-6. PubMed ID: 19632852
[TBL] [Abstract][Full Text] [Related]
8. Is there any maximum standardized uptake value variation among positron emission tomography scanners for mediastinal staging in non-small cell lung cancer?
Iskender I; Kadioglu SZ; Kosar A; Atasalihi A; Kir A
Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):965-9. PubMed ID: 21441257
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic ability of
Lee JW; Kim EY; Kim DJ; Lee JH; Kang WJ; Lee JD; Yun M
Eur Radiol; 2016 Dec; 26(12):4515-4523. PubMed ID: 26943133
[TBL] [Abstract][Full Text] [Related]
10. Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients.
Kim YK; Lee KS; Kim BT; Choi JY; Kim H; Kwon OJ; Shim YM; Yi CA; Kim HY; Chung MJ
Cancer; 2007 Mar; 109(6):1068-77. PubMed ID: 17311309
[TBL] [Abstract][Full Text] [Related]
11. Consideration of serum glucose levels during malignant mediastinal lymph node detection in non-small-cell lung cancer by FDG-PET.
Lee WW; Chung JH; Jang SJ; Eo JS; Park SY; Sung SW; So Y; Chung JK; Lee MC; Kim SE
J Surg Oncol; 2006 Dec; 94(7):607-13. PubMed ID: 17039492
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer.
Saydam O; Gokce M; Kilicgun A; Tanriverdi O
Med Oncol; 2012 Jun; 29(2):589-94. PubMed ID: 21380783
[TBL] [Abstract][Full Text] [Related]
13. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S
Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
[TBL] [Abstract][Full Text] [Related]
14. Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma.
Kuo WH; Wu YC; Wu CY; Ho KC; Chiu PH; Wang CW; Chang CJ; Yu CT; Yen TC; Lin C
Acad Radiol; 2012 Jun; 19(6):685-92. PubMed ID: 22459646
[TBL] [Abstract][Full Text] [Related]
15. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.
Al-Sarraf N; Aziz R; Gately K; Lucey J; Wilson L; McGovern E; Young V
Eur J Cardiothorac Surg; 2008 Jan; 33(1):104-9. PubMed ID: 17977738
[TBL] [Abstract][Full Text] [Related]
16. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?
Sivrikoz CM; Ak I; Simsek FS; Döner E; Dündar E
Thorac Cardiovasc Surg; 2012 Mar; 60(2):116-21. PubMed ID: 21692019
[TBL] [Abstract][Full Text] [Related]
17. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?
Hellwig D; Graeter TP; Ukena D; Groeschel A; Sybrecht GW; Schaefers HJ; Kirsch CM
J Nucl Med; 2007 Nov; 48(11):1761-6. PubMed ID: 17942814
[TBL] [Abstract][Full Text] [Related]
19. Comparison of objective criteria and expert visual interpretation to classify benign and malignant hilar and mediastinal nodes on 18-F FDG PET/CT.
Nguyen P; Bhatt M; Bashirzadeh F; Hundloe J; Ware R; Fielding D; Ravi Kumar AS
Respirology; 2015 Jan; 20(1):129-37. PubMed ID: 25263085
[TBL] [Abstract][Full Text] [Related]
20. Predictors of mediastinal staging and usefulness of pet in patients with stage IIIA (N2) or IIIB (N3) lung cancer.
Gullón JA; Villanueva MA; Sánchez-Antuña AA; Rodríguez MR; Álvarez-Navascues F; Allende J; Martínez-Muñiz MA; García-García JM
Clin Respir J; 2021 Jan; 15(1):42-47. PubMed ID: 33448698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
